“We have formulated a European vaccine strategy based on negotiations with a number of companies. The fact that member states decide to purchase vaccines from other manufacturers has already occurred in Hungary, but this is not the purpose of the strategy.” The EU chief spokesperson said.
BRUSSELS (EUROPA PRESS)-The European Commission strongly denied this Thursday that Germany intends to purchase the Russian Sputnik V vaccine against covid-19 on its own after obtaining EU health authorities’ approval. The EU’s strategy of centralized procurement of serum.
Specifically, the German Health Minister confirmed that the German government will hold bilateral negotiations with Moscow to study how many doses of Russian vaccines can arrive and when it will be clearly approved by the European Medicines Agency.
Member States can bilaterally purchase vaccines that are not included in the portfolio agreed at the European level. On the contrary, they cannot engage in “side negotiation” to purchase serums in a centralized strategy, such as serums from AstraZeneca, Pfizer/BioNTEch, Moderna, or Janssen.
He said in a statement to WDR on Wednesday that at an emergency meeting held on Wednesday, Spahn communicated Berlin’s intentions to other EU health ministers to assess EMA’s conclusions on the safety of AstraZeneca’s vaccines.
However, the German approach is different from the approach adopted by Hungary. Hungary has chosen to follow emergency procedures to approve the use of Sputnik V on its territory. On the other hand, the German government tends to wait for the EMA to first make favorable recommendations for Russian vaccines.
European health agencies are evaluating a series of data on the safety and effectiveness of the Sputnik V vaccine, but have not yet received a formal request to obtain sales permission in this block.